Proton Pump Inhibitors, Kidney Damage, and Mortality: An Updated Narrative Review
Description
Since their approval by the Food and Drug Administration (FDA) in 1989, proton pump inhibitors (PPIs) have become one of the most highly utilized drugs in the United States, assuming a position as one of the top 10 most prescribed medications in the